Farletuzumab ecteribulin [2407465-18-1]

TargetMol Chemicals

Farletuzumab ecteribulin

9

2407465-18-1

Chemical

Research Use Only

Farletuzumab ecteribulin

Farletuzumab ecteribulin (MORAb-202) is a highly cytotoxic antibody-drug conjugate (ADC) targeting human folate receptor alpha (FRA). This ADC comprises the humanized Farletuzumab antibody linked to Mal-PEG2-Val-Cit-PAB-eribulin through reduced interchain disulfide bonds, with an agent-to-antibody ratio of 4.0, demonstrating potent antitumor activity against FRA-positive cells in vitro.

3 years

-20°C

12352203